A report in the Journal of the American Medical Association (9/23-9/30/09) suggests that if information about maternal complication rates at training hospitals were generally available, a woman would do well to choose her obstetrician on the basis of where he or she did residency.
A report in the Journal of the American Medical Association (9/23-9/30/09) suggests that if information about maternal complication rates at training hospitals were generally available, a woman would do well to choose her obstetrician on the basis of where he or she did residency.
In a retrospective analysis of maternal complications that used data from nearly 5 million deliveries, more than 4,000 obstetricians, and more than 100 residency programs, researchers showed that a woman who chooses an obstetrician trained in a top-tier program has a 10.3% risk of a major complication compared with 13.6% if her obstetrician trained at a bottom-tier residency program (absolute difference, 3.3%; 95% confidence interval, 2.8%-3.8%).
These differences remained significant (P<.001) across 6 individual complication measures, conditional on delivery mode. For vaginal deliveries, investigators measured rates of laceration, hemorrhage, and "all others," including infectious and thrombotic complications. For cesarean deliveries, they measured hemorrhage, infection, and "all others," such as operative and thrombotic complications.
Thinner endometrial thickness linked to higher placenta accreta spectrum risk
November 29th 2024A recent study reveals that reduced endometrial thickness significantly increases the risk of placenta accreta spectrum disorders in women without prior cesarean deliveries using assisted reproductive technology.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More